Amy Simon - 31 Jan 2026 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Chief Medical Officer
Signature
By: /s/ Christine Bellon, Attorney-in-fact
Issuer symbol
BEAM
Transactions as of
31 Jan 2026
Net transactions value
$0
Form type
4
Filing time
02 Feb 2026, 16:05:05 UTC
Previous filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Simon Amy Chief Medical Officer C/O BEAM THERAPEUTICS INC., 238 MAIN STREET, CAMBRIDGE By: /s/ Christine Bellon, Attorney-in-fact 02 Feb 2026 0001963879

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $0 +88,500 $0.000000 88,500 31 Jan 2026 Common Stock 88,500 $27.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date.